25d • 💬 General Discussion
Big Pharma Just Went All-In on Bitcoin
A tiny biotech company just made a move that sounds crazy at first.
Propanc Biopharma, an Australian cancer research firm, secured $100 million in funding.
Their plan? Build a massive Bitcoin treasury.
Wait, what?
Here's the wild part: They're following MicroStrategy's playbook exactly.
Buy Bitcoin. Hold it. Never sell.
Use it as a strategic reserve asset on their balance sheet.
The company is still in clinical trials for a pancreatic cancer treatment.
They're not profitable yet. They're not even close to bringing a drug to market.
But they're betting that holding Bitcoin will strengthen their financial position long-term.
This isn't some crypto native company doing crypto things.
This is a traditional pharmaceutical company choosing Bitcoin as their primary treasury strategy.
And they're not alone anymore.
More and more companies outside crypto are starting to view Bitcoin as a legitimate reserve asset.
Not for speculation. For balance sheet strength.
MicroStrategy proved the model works. Now others are copying it.
The question is: How many more "non-crypto" companies will follow?
Because once this becomes normal, the game changes completely.
2
0 comments
Big Pharma Just Went All-In on Bitcoin
powered by
skool.com/beawhale-1893
We help builders & founders cut through Web3 noise - learn fast, network, and ship blockchain products web3 users love 🐋
Suggested communities
Powered by